Cospeptin, cosmedin and their uses

Details for Australian Patent Application No. 2005227903 (hide)

Owner The Board of Trustees of the Leland Stanford Junior University Janssen Pharmaceuticals N.V.

Inventors Hsu, Sheau Yu Teddy; Hsueh, Aaron J.W.; Prendergast, Clodagh; AvsianKretchmer, Orna; Morton, Magda F.; Shankley, Nigel P.; Barrett, Terrance D.

Agent FB Rice

Pub. Number AU-A-2005227903

PCT Pub. Number WO2005/094453

Priority 60/555,818 23.03.04 US

Filing date 22 March 2005

Wipo publication date 13 October 2005

International Classifications

C12N 15/00 (2006.01) Mutation or genetic engineering

Event Publications

21 September 2006 PCT application entered the National Phase

  PCT publication WO2005/094453 Priority application(s): WO2005/094453

27 September 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005227904-Eyeglasses and method of manufacture thereof

2005227897-Devices and methods to treat a patient